ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
23andMe Holding Company

23andMe Holding Company (ME)

0,6063
0,00
(0,00%)
Geschlossen 22 April 10:00PM
0,00
0,00
(0,00%)
Nach Börsenschluss: -

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,6063
Gebot
0,5062
Fragen
0,5063
Volumen
-
0,00 Tagesbereich 0,00
0,53 52-Wochen-Bereich 12,76
Marktkapitalisierung
Handelsende
0,6063
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
4.053.866
Ausgegebene Aktien
27.445.430
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-0,03
Gewinn pro Aktie (EPS)
-24,29
Erlöse
219,64M
Nettogewinn
-666,7M

Über 23andMe Holding Company

23andMe headquartered in Sunnyvale CA is a leading consumer genetics and research company. Founded in 2006 the companys mission is to help people access understand and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA auth... 23andMe headquartered in Sunnyvale CA is a leading consumer genetics and research company. Founded in 2006 the companys mission is to help people access understand and benefit from the human genome. 23andMe has pioneered direct access to genetic information as the only company with multiple FDA authorizations for genetic health risk reports. The company has created the worlds largest crowdsourced platform for genetic research with 80 percent of its customers electing to participate. The 23andMe research platform has generated more than 180 publications on the genetic underpinnings of a wide range of diseases conditions and traits. The platform also powers the 23andMe Therapeutics group currently pursuing drug discovery programs rooted in human genetics across a spectrum of disease areas including oncology respiratory and cardiovascular diseases in addition to other therapeutic areas. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Blank Checks
Website
Hauptsitz
Wilmington, Delaware, USA
Gegründet
2021
23andMe Holding Company is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ME. The last closing price for 23andMe was US$0,61. Over the last year, 23andMe shares have traded in a share price range of US$ 0,53 to US$ 12,76.

23andMe currently has 27.445.430 shares in issue. The market capitalisation of 23andMe is US$16,64 million. 23andMe has a price to earnings ratio (PE ratio) of -0.03.

ME Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
1000.60630.60630.606300CS
4-0.3337-35.50.941.370.53117243980.74116077CS
12-2.8437-82.42608695653.453.60.5340538660.811391CS
26-4.3437-87.75151515154.955.3480.5320901701.03557483CS
52-9.2337-93.83841463419.8412.760.5329134575.67466685CS
156-68.1937-99.1187568.8126.20.53347950427.00915029CS
260-131.1937-99.5399848255131.8273.60.53280498248.32695917CS

ME - Frequently Asked Questions (FAQ)

What is the current 23andMe share price?
The current share price of 23andMe is US$ 0,6063
How many 23andMe shares are in issue?
23andMe has 27.445.430 shares in issue
What is the market cap of 23andMe?
The market capitalisation of 23andMe is USD 16,64M
What is the 1 year trading range for 23andMe share price?
23andMe has traded in the range of US$ 0,53 to US$ 12,76 during the past year
What is the PE ratio of 23andMe?
The price to earnings ratio of 23andMe is -0,03
What is the cash to sales ratio of 23andMe?
The cash to sales ratio of 23andMe is 0,08
What is the reporting currency for 23andMe?
23andMe reports financial results in USD
What is the latest annual turnover for 23andMe?
The latest annual turnover of 23andMe is USD 219,64M
What is the latest annual profit for 23andMe?
The latest annual profit of 23andMe is USD -666,7M
What is the registered address of 23andMe?
The registered address for 23andMe is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the 23andMe website address?
The website address for 23andMe is www.23andme.com
Which industry sector does 23andMe operate in?
23andMe operates in the BLANK CHECKS sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
UPXIUpexi Inc
US$ 9,83
(328,32%)
100,38M
SHFSSHF Holdings Inc
US$ 4,17
(87,00%)
43,5M
MLGOMicroAlgo Inc
US$ 11,84
(74,63%)
78,43M
MKDWMKDWELL Tech Inc
US$ 0,4027
(73,35%)
40,8M
MTENMingteng International Corporation Inc
US$ 6,24
(47,87%)
317,66k
AIEVThunder Power Holdings Inc
US$ 0,049999
(-63,02%)
6,25M
LXEHLixiang Education Holding Company Ltd
US$ 2,88
(-57,89%)
1,57M
AREBAmerican Rebel Holdings Inc
US$ 2,38
(-53,88%)
11,97M
SXTCChina SXT Pharmaceuticals Inc
US$ 1,029
(-52,36%)
1,66M
RTCBaijiayun Group Ltd
US$ 0,1862
(-49,68%)
7,75M
DMNDamon Inc
US$ 0,0041
(20,59%)
621,47M
NVDANVIDIA Corporation
US$ 96,91
(-4,51%)
288,68M
STSSSharps Technology Inc
US$ 0,0319
(-0,31%)
162,99M
RSLSReShape Lifesciences Inc
US$ 0,383
(23,67%)
152,04M
TSLLDirexion Daily TSLA Bull 2X Trust ETF
US$ 6,7742
(-11,68%)
151,31M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock